Sign In
Buy TMDX
$75.51
-3.28 (-4.16%)
At Close: Jun 22, 2026
SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating TransMedics Group, Inc. (NASDAQ: TMDX) on behalf of investors who suffered losses and whether those losses may be rec
TransMedics: Why I'm Still Bullish After The Collapse
09:44am, Tuesday, 09'th Jun 2026
TransMedics (TMDX) faces decelerating revenue growth, margin pressure, and increased investment, yet maintains strong market share gains and competitive positioning. TMDX's logistics and clinical serv
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market
08:20am, Friday, 05'th Jun 2026
Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead.
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?
12:35pm, Thursday, 04'th Jun 2026
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock?
This Healthcare Infrastructure Stock Is Risky, But the Upside Looks Huge
06:00pm, Tuesday, 02'nd Jun 2026
TransMedics (TMDX +1.19%) has been hit hard as investors question margins, spending, and execution. But beneath the sell-off, the company's Organ Care System, aviation network, and National OCS Progra
Reasons to Retain TransMedics Stock in Your Portfolio for Now
02:01pm, Thursday, 28'th May 2026
TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.
TransMedics: Despite Earnings Miss, Growth Story Remains Intact
01:28pm, Monday, 25'th May 2026
TransMedics remains a 'Strong Buy' despite a 50% stock decline and Q1 2026 earnings miss, supported by robust long-term growth initiatives. TMDX's portfolio expansion includes CHOPS as a complementary
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Thursday, 21'st May 2026
ANDOVER, Mass., May 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-st
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference
04:05pm, Tuesday, 19'th May 2026
ANDOVER, Mass., May 19, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-st
TransMedics: Cheaper, But Still Priced For Perfection
07:56pm, Wednesday, 06'th May 2026
TransMedics Group, Inc. remains a Sell as its valuation still bakes in near-perfect execution, despite the stock being nearly 40% cheaper since October. TMDX's valuation implies sustaining some combin
TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins Fall
12:55pm, Wednesday, 06'th May 2026
TransMedics' Q1 revenues rise 21% on strong OCS demand, but a sharp EPS miss and margin pressure send shares down despite continued logistics growth.
TransMedics Group, Inc. (TMDX) Q1 2026 Earnings Call Transcript
08:41pm, Tuesday, 05'th May 2026
TransMedics Group, Inc. (TMDX) Q1 2026 Earnings Call Transcript
TransMedics (TMDX) Reports Q1 Earnings: What Key Metrics Have to Say
08:01pm, Tuesday, 05'th May 2026
While the top- and bottom-line numbers for TransMedics (TMDX) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compa
TransMedics (TMDX) Q1 Earnings and Revenues Miss Estimates
07:10pm, Tuesday, 05'th May 2026
TransMedics (TMDX) came out with quarterly earnings of $0.3 per share, missing the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.7 per share a year ago.
TransMedics Reports First Quarter 2026 Financial Results
04:05pm, Tuesday, 05'th May 2026
ANDOVER, Mass., May 5, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-sta
